AI Analysis
Log in to generate an AI summary for this stock.
Log in to generate a MOAT report for this stock.
Log in to generate an earnings report for this stock.
Log in to generate an operating leverage report for this stock.
Log in to generate a management report for this stock.
Log in to generate a valuation report for this stock.
Alcon Inc.
Video analysis: ALC
All videosNo video analysis for this stock yet. Request one from our team.
News: ALC
Is it a Prudent Move to Retain ALC Stock in Your Portfolio Now?
Alcon's acquisitions, partnerships and new product launches support growth, but tariffs and intense competition remain key risks.
Alcon: A Re-Rating In Eyesight
Alcon is a structurally advantaged ophthalmology leader with a durable equipment-to-consumables model and strong recurring revenue streams. At $72, ALC trades at ~18x forward earnings, reflecting mid-teens EPS growth but pricing in neither margin expansion nor pipeline optionality. Management targets 25% core operating margin by FY2027E, with current core EPS guidance raised to +12–15% growth and significant capital returns underway.
Alcon Launches UNITY M, a Premium Ophthalmic Microscope Delivering Precise Control
GENEVA--(BUSINESS WIRE)--Alcon Launches UNITY® M, a Premium Ophthalmic Microscope Delivering Precise Control.
Alcon Prices EUR 500 Million Senior Notes Offering
GENEVA--(BUSINESS WIRE)--Alcon Prices EUR 500 Million Senior Notes Offering.
Alcon: A Strong Company Trading Close To Its Intrinsic Value, Buy
Alcon reported strong core operating profit (barring a one-time non-cash $402 million charge) during the quarter, up 17%. The company raised its full-year 2026 profit forecast for the second consecutive quarter. My DCF valuation states the stock is undervalued by 5.52%. I rate ALC a buy.
Bill Ackman Just Disclosed 6 New Positions, and 4 of Them Are Financial Stocks. Here's What He's Betting On.
The famous long-term investor and his team made notable changes to Pershing Square's equity portfolio.
Why Netflix Stock Popped Today
Bill Ackman (Trades, Portfolio)'s Pershing Square Capital Management has built a new position in Netflix (NFLX), returning to the streaming company after a cost
Bill Ackman Buys Back Into Netflix Four Years After Selling at a Loss
Bill Ackman (Trades, Portfolio) disclosed six new holdings, buying Netflix (NFLX), Visa (V), Mastercard (MA), eye care company Alcon (ALC), exchange operator In
Similar companies
-
ResMed Inc.
RMD
·
New York Stock Exchange
Compare
-
IQVIA Holdings Inc.
IQV
·
New York Stock Exchange
Compare
-
Agilent Technologies, Inc.
A
·
New York Stock Exchange
Compare
-
GE HealthCare Technologies Inc.
GEHC
·
NASDAQ
Compare
-
Humana Inc.
HUM
·
New York Stock Exchange
Compare
-
Becton, Dickinson and Company
BDX
·
New York Stock Exchange
Compare